secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0001213900-24-033856
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar Therapeutics regains Nasdaq minimum bid price compliance
---------------------------------------------------------------

- Received Nasdaq notice on April 17, 2024, confirming compliance regained as of April 16, 2024.
- Common stock closing bid price met $1.00 minimum for 10 consecutive business days.
- Stock had been non-compliant since May 2023 and transferred to Nasdaq Capital Market in November 2023.
- Additional 180-day extension had been granted until May 20, 2024.
- Continued listing on Nasdaq Capital Market is now secure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390024033856/0001213900-24-033856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390024033856/ea0204090-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-033856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer